Experience with continuous levodopa enteral infusion (Duodopa®)in patients with advanced Parkinson's disease in a secondary level hospital

Rinne, 1983, Problems associated with long-term levodopa treatment of Parkinson's disease, Acta Neurol Scand, 95, 19, 10.1111/j.1600-0404.1983.tb01513.x Fahn, 2008, How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?, Ann Neurol, 64, S56, 10.1002/ana.21453 Poewe, 2000, an underutilized therapy for Parkinson's disease, Mov Disord, 5, 789, 10.1002/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H Krack, 2003, Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease, N Engl J Med, 349, 1925, 10.1056/NEJMoa035275 Bredberg, 1993, Intraduodenal infusion of a waterbased levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease, Eur J Clin Pharmacol, 45, 117, 10.1007/BF00315491 Nyholm, 2008, Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure, Clin Neuropharmacol, 31, 63, 10.1097/WNF.0b013e3180ed449f Yañez-Baña, 2007, Infusión de Duodopa® en la enfermedad de Parkinson, Revista Española de Trastornos del Movimiento, 7, 21 Hoenh, 1967, onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Schwab, 1969, Projection technique for evaluating surgery in Parkinson's disease, 152 Peto, 1995, The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease, Qual Life Res, 4, 241, 10.1007/BF02260863 1976, p.217 Welter, 2002, Clinical predictive factors of subthalamic stimulation in Parkinson's disease, Brain, 125, 575, 10.1093/brain/awf050 Nilsson, 2001, Duodenal levodopa infusion in Parkinson's disease–long-term experience, Acta Neurol Scand, 104, 343, 10.1034/j.1600-0404.2001.00153.x Antonini, 2007, Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome, Mov Disord, 22, 1145, 10.1002/mds.21500 Valldeoriola, 2008, Continuous duodenal levodopa infusion - The Barcelona Experience, European Neurological Review Suppl.III International Forum on Advanced Parkinson's Disease, 3, 25 Devos, 2009, Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease, Mov Disord, 24, 993, 10.1002/mds.22450 Puente, 2010, Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of life, Parkinsonism Relat Disord, 16, 218, 10.1016/j.parkreldis.2009.07.015 Reijnders, 2008, A systematic review of prevalence studies of depression in Parkinson's disease, Mov Disord, 23, 183, 10.1002/mds.21803 Nyholm, 2005, Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease, Neurology, 64, 216, 10.1212/01.WNL.0000149637.70961.4C Syed, 1998, Ten years’ experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease, Mov Disord, 13, 336, 10.1002/mds.870130222 Nyholm, 2003, Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets, Clin Neuropharmacol, 26, 156, 10.1097/00002826-200305000-00010 Antonini, 2008, Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease, Neurodegener Dis, 5, 244, 10.1159/000113714 Honig, 2009, Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life, Mov disord, 24, 1468, 10.1002/mds.22596 Mouradian, 1990, Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease, Ann Neurol, 27, 18, 10.1002/ana.410270105 Antonini, 2007, Continuous dopaminergic stimulation–from theory to clinical practice, Parkinsonism Relat Disord, 13 Suppl, S24, 10.1016/j.parkreldis.2007.06.002 Nyholm, 2005, Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements, Neurology, 65, 1506, 10.1212/01.wnl.0000183146.78892.3f Santos-García, 2009, Suicide following duodenal levodopa infusion for Parkinson's disease, Mov Disord, 24, 2029, 10.1002/mds.22708 Antonini, 2009, Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management, Expert Rev Neurother, 9, 859, 10.1586/ern.09.48 Sánchez-Castañeda, 2010, Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients, Prog Neuropsychopharmacol Biol Psychiatry, 34, 250, 10.1016/j.pnpbp.2009.10.021